Covid-19: Lancet Praises India’s Vaccine Development, Cluster Testing and Early Shutdown Initiatives


The Lancet has assessed how India handled the Covid-19 situation and gave a mixed review. In his editorial titled “Covid-19 in India: The Dangers of False Optimism,” he said that India is clearly facing a “dangerous period,” although the country has responded well in many respects, “especially for such a large and diverse nation. “. .

“India has also been at the forefront of efforts to develop and manufacture a vaccine, both through domestic vaccine candidates and manufacturers such as the Serum Institute of India which prepares production capacity for internationally developed vaccine candidates,” he noted. the British medical journal.

Also read: Can Covid-19 affect the heart? Probably says study

“The rapidly growing number of cases, coupled with the continued relaxation of restrictions, is creating an atmosphere of fatalism mixed with false optimism that undermines the effective use of non-pharmaceutical interventions such as masks and physical distancing,” he added.

4 things the Lancet gives India credit for

* Early blockage, which was praised by the World Health Organization (WHO)

* Implementation of pooled tests, in which multiple swab samples are analyzed using an RT-PCR test kit. If the group’s result is negative, the entire group can be considered negative. If the group tests positive, at least one of the samples is positive.

* Research for vaccine

* Increase the provision of tertiary care, including access to specialized equipment such as ventilators.

4 things the Lancet discredits India for

* Atmosphere of fatalism mixed with false optimism that is undermining the importance of social distancing, wearing masks, etc.

* ICMR supports the treatment of Covid-19 with hydroxychloroquine despite insufficient evidence.

* Parallel crisis of economic slowdown, including the migration crisis.

* Present the current situation in India with too positive a twist.

.